Sentences with phrase «molecular medicine research»

Comparative Orthopedic Molecular Medicine Research Laboratories, Department of Veterinary Clinical Sciences, College of Veterinary Medicine, The Ohio State University, Columbus, OH 43210, USA.

Cellular and Molecular Medicine Research, quarterly, ISSN 0000 - 0000 (print), 0000 - 0000 (online), published by Elmer Press Inc..

3, No. 1, Mar 2018, published Cellular and Molecular Medicine Research, Vol.

Cellular and Molecular Medicine Research Elmer Press Inc 9225 Leslie Street, Suite 201 Richmond Hill, Ontario L4B 3H6, Canada Tel: [phone] Fax: [phone] Email: [email protected]

Cellular and Molecular Medicine Research is published by Elmer Press Inc..

I am greatly honored to be appointed as the inaugural Editor - in - Chief of Cellular and Molecular Medicine Research (CMMR), an international, open access, and peer - reviewed journal.

With hard work and full support from the Editorial Board and the editorial office, I believe the journal will attract submissions from scientists as well as clinicians in the field of cellular and molecular medicine research.

The Centre in Umeå focuses on molecular medicine research on cancer, metabolic diseases including diabetes, neuroscience and infection biology.

Not exact matches

Materials provided by CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences.

«Once this novel tumor - homing agent binds to the EphA2 receptor, the oncogene functions as a cancer - specific molecular Trojan horse for paclitaxel, carrying the drug inside the cancel cell, killing the cell, and thwarting metastasis,» said Maurizio Pellecchia, a professor of biomedical sciences at UCR's School of Medicine who led the research.

Editor's Note (10/2/17): Seventeen years before the Nobel Prize in Physiology or Medicine went to three U.S. scientists for their research on biological clocks, one of them, Michael W. Young, set out an account in Scientific American describing the genetic studies that identified the «molecular timepieces» that are ubiquitous throughout the animal kingdom.

The new study's findings build upon prior research by Dr. Roger Lo, a professor of medicine (dermatology) and molecular and medical pharmacology at the David Geffen School of Medicine medicine (dermatology) and molecular and medical pharmacology at the David Geffen School of Medicine Medicine at UCLA.

Addressing a molecular medicine congress, Watson, co-discoverer of the structure of DNA and a founder of the Human Genome Project, urged Germany to overcome widespread hostility to genetics research and focus on the great benefits that applying genome research can offer humankind.

Detlev Ganten, head of Berlin's Max Delbrück Center for Molecular Medicine, which co-organized the conference, says he agrees that Germany «never fully purged itself» of the sins of some Nazi - era geneticists, and is still «psychologically not well prepared» for such research.

Institute researchers Dr Ashley Ng, Dr Maria Kauppi, Professor Warren Alexander, Professor Don Metcalf and colleagues from the institute's Cancer and Haematology and Molecular Medicine divisions led the research, published in the journal Proceedings of the National Academy of Sciences.

Together with a research group led by Dr. Ari Waisman, the head of the Institute for Molecular Medicine at the University Medical Center in Mainz, Korn and his team have found an explanation for this phenomenon.

The research was conducted through the Program of Experimental and Molecular Medicine at Dartmouth College.

Gene Yeo, a professor of cellular and molecular medicine at UCSD, led the research and showed he could target RNA in living cells, a first step toward treating diseases like muscular dystrophy and neurodegeneration.

This work provides us with a promising new tool in the CRISPR toolbox,» said author Dr. Eric Olson, Chairman of Molecular Biology, Co-Director of the UT Southwestern Wellstone Muscular Dystrophy Cooperative Research Center, and Director of the Hamon Center for Regenerative Science and Medicine.

«Open data is vital for progress and research,» added TSRI Assistant Professor of Molecular and Experimental Medicine Ben Good.

UTSW co-authors include: Co-lead author Maria Winter, a research associate; Dr. Luisella Spiga, a postdoctoral researcher; visiting fellow Lisa Büttner; graduate students Elizabeth Hughes and Caroline Gillis, all of Microbiology; Dr. Breck Duerkop, Instructor, Immunology; Cassie Behrendt, a research technician, Immunology; Dr. Lora Hooper, Professor and Chair of Immunology with appointments in Microbiology and in the Center for the Genetics of Host Defense, a HHMI Investigator and holder of the Jonathan W. Uhr, M.D. Distinguished Chair in Immunology, and the Nancy Cain and Jeffrey A. Marcus Scholar in Medical Research, in Honor of Dr. Bill S. Vowell; Dr. Luis Sifuentes - Dominguez, Instructor of Pediatrics; Dr. Kayci Huff - Hardy, clinical fellow, Internal Medicine in the Division of Digestive and Liver Diseases; Dr. Andrew Koh, Associate Professor of Pediatrics and Microbiology and in the Harold C. Simmons Comprehensive Cancer Center as well as Director of Pediatric Hematopoietic Stem Cell Transplantation at Children's Health; and Dr. Ezra Burstein, Professor of Internal Medicine and Molecular Biology and Chief of the Division of Digestive and Liver Dresearch associate; Dr. Luisella Spiga, a postdoctoral researcher; visiting fellow Lisa Büttner; graduate students Elizabeth Hughes and Caroline Gillis, all of Microbiology; Dr. Breck Duerkop, Instructor, Immunology; Cassie Behrendt, a research technician, Immunology; Dr. Lora Hooper, Professor and Chair of Immunology with appointments in Microbiology and in the Center for the Genetics of Host Defense, a HHMI Investigator and holder of the Jonathan W. Uhr, M.D. Distinguished Chair in Immunology, and the Nancy Cain and Jeffrey A. Marcus Scholar in Medical Research, in Honor of Dr. Bill S. Vowell; Dr. Luis Sifuentes - Dominguez, Instructor of Pediatrics; Dr. Kayci Huff - Hardy, clinical fellow, Internal Medicine in the Division of Digestive and Liver Diseases; Dr. Andrew Koh, Associate Professor of Pediatrics and Microbiology and in the Harold C. Simmons Comprehensive Cancer Center as well as Director of Pediatric Hematopoietic Stem Cell Transplantation at Children's Health; and Dr. Ezra Burstein, Professor of Internal Medicine and Molecular Biology and Chief of the Division of Digestive and Liver Dresearch technician, Immunology; Dr. Lora Hooper, Professor and Chair of Immunology with appointments in Microbiology and in the Center for the Genetics of Host Defense, a HHMI Investigator and holder of the Jonathan W. Uhr, M.D. Distinguished Chair in Immunology, and the Nancy Cain and Jeffrey A. Marcus Scholar in Medical Research, in Honor of Dr. Bill S. Vowell; Dr. Luis Sifuentes - Dominguez, Instructor of Pediatrics; Dr. Kayci Huff - Hardy, clinical fellow, Internal Medicine in the Division of Digestive and Liver Diseases; Dr. Andrew Koh, Associate Professor of Pediatrics and Microbiology and in the Harold C. Simmons Comprehensive Cancer Center as well as Director of Pediatric Hematopoietic Stem Cell Transplantation at Children's Health; and Dr. Ezra Burstein, Professor of Internal Medicine and Molecular Biology and Chief of the Division of Digestive and Liver DResearch, in Honor of Dr. Bill S. Vowell; Dr. Luis Sifuentes - Dominguez, Instructor of Pediatrics; Dr. Kayci Huff - Hardy, clinical fellow, Internal Medicine in the Division of Digestive and Liver Diseases; Dr. Andrew Koh, Associate Professor of Pediatrics and Microbiology and in the Harold C. Simmons Comprehensive Cancer Center as well as Director of Pediatric Hematopoietic Stem Cell Transplantation at Children's Health; and Dr. Ezra Burstein, Professor of Internal Medicine and Molecular Biology and Chief of the Division of Digestive and Liver Diseases.

The research is published today in EMBO Molecular Medicine.

«If we can define the boundaries of molecular targets in saliva, then we can ask what the constituents in saliva are that can mark someone who has pre-diabetes or the early stages of oral cancer or pancreatic cancer — and we can utilize this knowledge for personalized medicine,» said Dr. David Wong, a senior author of the research and UCLA's Felix and Mildred Yip Endowed Professor in Dentistry.

Lately I have met with faculty engaged in research on bullying, visual processing, criminology, molecular biology, dance medicine, gender and work, 20th century Canadian social history, labour, the homeless, and many others.

After that, he worked for a while on a research fellowship at the University of Iowa Carver College of Medicine, studying molecular signaling and trying to identify drug targets.

TICK TOCK For their research identifying the molecular workings of the biological clock, Jeffrey C. Hall, Michael Rosbash and Michael W. Young (from left to right) share the 2017 Nobel Prize in physiology or medicine.

Additional coauthors included Dr. Axel Concepcion, Department of Pathology, NYU School of Medicine; Dr. Charles Smith, Department of Anatomy & Cell Biology and Faculty of Dentistry, McGill University, Facility for Electron Microscopy Research; Drs. Sonal Srikanth and Yousang Gwack, Department of Physiology, University of California, Los Angeles; Dr. Michael Paine, Center for Craniofacial Molecular Biology, Ostrow School of Dentistry, University of Southern California; and Dr. Michael Hubbard, Departments of Paediatrics and Pharmacology, The University of Melbourne.

Co-authors of the study include: Jean - Sébastien Jouhanneau, Leiron Ferrarese, Luc Estebanez and James F.A. Poulet from the Department of Neuroscience at the Max Delbrück Center for Molecular Medicine in Berlin and the Neuroscience Research Center at the Charité - Universitätsmedizin Berlin; Nick J. Audette, a doctoral student in the Department of Biological Sciences at Carnegie Mellon and the CNBC; and Michael Brecht from the Bernstein Center for Computational Neuroscience at Humboldt University in Berlin and the the Neuroscience Research Center at the Charité - Universitätsmedizin Berlin.

The research was led by TAU postgraduate student Dr. Elena Milanesi under the guidance of Dr. David Gurwitz of the Department of Human Molecular Genetics and Biochemistry of TAU's Sackler Faculty of Medicine and Sagol School of Neuroscience and Dr. Noam Shomron of the Department of Cell and Developmental Biology at TAU's Sackler Faculty of Medicine, in collaboration with Sackler graduate student Adva Hadar and Prof. Haim Werner of TAU's Sackler Faculty of Medicine, along with researchers in Italy and Germany.

Scientists are taking medical imaging research and drug discovery to a new level by developing a molecular imaging system that combines several advanced technologies for all - in - one imaging of both tissue models and live subjects, say presenters at the 2015 Annual Meeting of the Society of Nuclear Medicine and Molecular Imagingmolecular imaging system that combines several advanced technologies for all - in - one imaging of both tissue models and live subjects, say presenters at the 2015 Annual Meeting of the Society of Nuclear Medicine and Molecular ImagingMolecular Imaging (SNMMI).

Masahiro Morita, Ph.D., assistant professor of molecular medicine in the Joe R. & Teresa Lozano Long School of Medicine at UT Health San Antonio, contributed to the rmedicine in the Joe R. & Teresa Lozano Long School of Medicine at UT Health San Antonio, contributed to the rMedicine at UT Health San Antonio, contributed to the research.

«This is the first time that this specific protein - protein signaling complex has been identified in GBM, and it gives us a new potential target for drug development,» says Fisher, Thelma Newmeyer Corman Endowed Chair in Cancer Research and co-leader of the Cancer Molecular Genetics research program at VCU Massey, professor and chair of the Department of Human and Molecular Genetics at the VCU School of Medicine, and director of tResearch and co-leader of the Cancer Molecular Genetics research program at VCU Massey, professor and chair of the Department of Human and Molecular Genetics at the VCU School of Medicine, and director of tresearch program at VCU Massey, professor and chair of the Department of Human and Molecular Genetics at the VCU School of Medicine, and director of the VIMM.

Prof. Raymond Kaempfer, the Dr. Philip M. Marcus Professor of Molecular Biology and Cancer Research at the Institute for Medical Research Israel - Canada (IMRIC), in the Hebrew University's Faculty of Medicine, explains: «Rather than targeting the bacterial pathogens, which can then mutate to develop antibiotic resistance, host - oriented therapeutics have the advantage of remaining effective even against infections with antibiotic - resistant strains.

Alkek Center for Metagenomics and Microbiome Research, Department of Molecular Virology and Microbiology, Baylor College of Medicine, Houston, TX 77030, USA.

Jean - Pierre Issa, MD, Director of the Fels Institute for Cancer Research and Molecular Biology at Temple University School of Medicine and co-Leader of the Cancer Epigenetics Program at the Fox Chase Cancer Center is lead author of the study, which has been published August 19 in the journal, Lancet Oncology.

«While the importance of taurine is yet to be fully understood, this research shows that vitamin B12 plays a role in regulating taurine production and that taurine plays an important role in bone formation,» Dr Vidya Velagapudi, Head of the Metabolomics Unit at the Institute for Molecular Medicine Finland.

Researchers from UT Southwestern's Charles and Jane Pak Center for Mineral Metabolism and Clinical Research and Internal Medicine's Division of Nephrology recently published work in Nature that reveals the molecular structure of the so - called «anti-aging» protein alpha Klotho (a-Klotho) and how it transmits a hormonal signal that controls a variety of biologic processes.

With an M.A. in human genetics and molecular biology from Johns Hopkins University School of Medicine and a B.S. in biochemistry from New Mexico State University, Cordova has held research internships at those institutions as well as at the Fred Hutchinson Cancer Research Center and at the University of Texas - research internships at those institutions as well as at the Fred Hutchinson Cancer Research Center and at the University of Texas - Research Center and at the University of Texas - Houston.

The research, led by Ali Torkamani, assistant professor of Molecular and Experimental Medicine at TSRI and assistant professor and director of Genome Informatics at STSI, was published October 11, 2016, in the Journal of the American Medical Association (JAMA).

The research, which appears online this week in Molecular Systems Biology, was conducted at the Texas Medical Center in Houston by researchers from Rice, the University of Texas MD Anderson Cancer Center and Baylor College of Medicine.

This idea has been the major focus of the work in the laboratory of Dr. Ehud Cohen of the Department of Biochemistry and Molecular Biology, at the Institute for Medical Research Israel - Canada in the Hebrew University of Jerusalem's Faculty of Medicine.

A relatively new biomarker called prostate - specific membrane antigen (PSMA) is the bullseye for three new magnetic resonance imaging (MRI) agents that bind to the protein in not only prostate cancer, but a range of tumor types, according to research unveiled at the 2015 annual meeting of the Society of Nuclear Medicine and Molecular Imaging (SNMMI).

Dr. Feilotter is an associate professor in the Department of Pathology and Molecular Medicine at Queen's University, where she maintains an active research program dedicated to biomarker discovery and validation in a variety of human diseases.

«Whenever we use such a technology to examine an organ or an organism, we find not only familiar cell types, but also unknown and rare ones,» says Dr. Jan Philipp Junker, head of the Quantitative Developmental Biology research group at the Max Delbrück Center for Molecular Medicine in the Helmholtz Association (MDC).

«We challenged a current dogma in the field that emphasized PLK1's role in mitosis (cell division) as a primary mechanism for cancer growth,» says Zheng Fu, Ph.D., lead investigator on the study, member of the Cancer Molecular Genetics research program at VCU Massey Cancer Center and assistant professor in the Department of Human and Molecular Genetics at the VCU School of Medicine.

Germany's Max Delbrück Center for Molecular Medicine (MDC) Berlin Buch and the Fu Wai Hospital of the Chinese Academy of Medical Sciences (CAMS) are building a new gene research laboratory in Beijing, the aim being to identify genes that play a key role in the pathogenesis of cardiovascular diseases.

Applying a new method that is used mainly in stem - cell research and regenerative medicine, researchers from the Technical University of Munich have now devised a robust intestinal model for molecular research into incretin release in a test tube (in vitro).

To help in his hunt for disease genes, Pe'er founded The Ashkenazi Genome Consortium (TAGC) in September 2011 with Todd Lencz, an investigator at The Feinstein Institute for Medical Research, director of the Laboratory of Analytic Genomics at the Zucker Hillside Hospital, and associate professor of molecular medicine and psychiatry at the Hofstra North Shore - LIJ School of Mmedicine and psychiatry at the Hofstra North Shore - LIJ School of MedicineMedicine.

As a young Chinese scientist, I am participating in an exchange program with Germany, having joined the Chinese - German microsatellite genome research project at the Max Delbrück Center for Molecular Medicine (MDC) in Berlin, Germany.

The research team, led by Haitao Wang, PhD, a senior research investigator, Robert Pignolo, MD, PhD, an associate professor in the division of Geriatrics and the Ian Cali Distinguished Clinician - Scientist at the Center, and Frederick S. Kaplan, MD, the Isaac & Rose Nassau Professor of Orthopaedic Molecular Medicine and Chief of the division of Molecular Orthopaedic Medicine, published their findings in the Journal of Bone and Mineral Research thiresearch team, led by Haitao Wang, PhD, a senior research investigator, Robert Pignolo, MD, PhD, an associate professor in the division of Geriatrics and the Ian Cali Distinguished Clinician - Scientist at the Center, and Frederick S. Kaplan, MD, the Isaac & Rose Nassau Professor of Orthopaedic Molecular Medicine and Chief of the division of Molecular Orthopaedic Medicine, published their findings in the Journal of Bone and Mineral Research thiresearch investigator, Robert Pignolo, MD, PhD, an associate professor in the division of Geriatrics and the Ian Cali Distinguished Clinician - Scientist at the Center, and Frederick S. Kaplan, MD, the Isaac & Rose Nassau Professor of Orthopaedic Molecular Medicine and Chief of the division of Molecular Orthopaedic Medicine, published their findings in the Journal of Bone and Mineral Research thiResearch this month.